Destiny Pharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Destiny Pharma generated cash of -$5,184,718, which is more than the previous year. Cash used in financing activities reached the amount of $6,744,704 last year. Net change in cash is therefore $1,479,142.
Cash Flow
| 2014 | -1.55M | 9.70K | 3.01M |
|---|---|---|---|
| 2015 | -900.56K | 5.11K | 10K |
| 2016 | -988.04K | 396 | 1.35M |
| 2017 | -2.15M | -5.01M | 17.40M |
| 2018 | -4.72M | 58.22K | 0 |
| 2019 | -4.56M | 4.97M | 7.07K |
| 2020 | -5.42M | -2.26M | 9.94M |
| 2021 | -5.07M | -30.26K | 6.51K |
| 2022 | -5.82M | -1.06K | 6.08M |
| 2023 | -5.18M | -80.84K | 6.74M |
DEST.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 4.90M | 4.64M | 9.74M | 7.47M | 7.06M | 11.72M | 1.48M | 1.11M | 2.00M | 537.26K |
Operating activities | ||||||||||
Net income | -5.65M | -6.50M | -5.33M | -5.41M | -4.70M | -5.16M | -2.97M | -1.44M | -1.19M | -2.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 6.19K | 12.32K | 12.51K | 16.88K | 18.44K | 9.66K | 2.07K | 1.33K | 778 | 805 |
Stock-based compensation expense | 475.47K | 533.82K | 405.85K | 139.49K | 203.65K | 0 | 709.97K | 200.85K | 283.87K | 367.46K |
| Deferred income tax benefit | 475.47K | 533.82K | 405.85K | 139.49K | 203.65K | 0 | 709.97K | 200.85K | 283.87K | 367.46K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -26.68K | 14.31K | 198.33K | -379.29K | -79.8K | -23.16K | -77.93K | 17.23K | 200.81K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -5.18M | -5.82M | -5.07M | -5.42M | -4.56M | -4.72M | -2.15M | -988.04K | -900.56K | -1.55M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -5M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -80.84K | -1.06K | -30.26K | -2.26M | -20.94K | -17.77K | -23.23K | 0 | -2.67K | -798 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -80.84K | -1.06K | -30.26K | -2.26M | 4.97M | 58.22K | -5.01M | 396 | 5.11K | 9.70K |
Financing activities | ||||||||||
Common Stock Issued | 6.74M | 6.08M | 6.51K | 9.94M | 7.07K | 0 | 17.40M | 1.35M | 10K | 3.01M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 6.74M | 6.08M | 6.51K | 9.94M | 7.07K | 0 | 17.40M | 1.35M | 10K | 3.01M |
Net Change In Cash | 1.47M | 257.89K | -5.09M | 2.26M | 418.82K | -4.66M | 10.24M | 362.91K | -885.44K | 1.46M |
Cash at end of period | 6.38M | 4.90M | 4.64M | 9.74M | 7.47M | 7.06M | 11.72M | 1.48M | 1.11M | 2.00M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |